# A Clinical Trial Evaluating the Safety and Efficacy of IDP-110 in Patients With Acne Vulgaris

> **NCT00663286** · PHASE3 · COMPLETED · sponsor: **Dow Pharmaceutical Sciences** · enrollment: 1399 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** IDP-110
- **DRUG:** Clindamycin
- **DRUG:** Benzoyl peroxide
- **DRUG:** Vehicle

## Key facts

- **NCT ID:** NCT00663286
- **Lead sponsor:** Dow Pharmaceutical Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2007-08
- **Final completion:** —
- **Target enrollment:** 1399 (ACTUAL)
- **Last updated:** 2008-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00663286

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00663286, "A Clinical Trial Evaluating the Safety and Efficacy of IDP-110 in Patients With Acne Vulgaris". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00663286. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*